Labeling Pilot for FDF Country of Origin, API Country of Origin, and KSM Country of Origin for Pharmaceutical Products

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is conducting market research to gauge interest from U.S. and international pharmaceutical manufacturers in a voluntary labeling pilot. The pilot aims to add country‑of‑origin data for finished dose forms (FDF), active pharmaceutical ingredients (API), and key starting materials (KSM) on product packaging or accompanying documentation, potentially using QR codes or links for extensive data. Manufacturers would provide information on a per‑lot basis, describe any production or administrative impact, and outline capabilities for traceability, timelines, and cost considerations. Responses are purely informational and do not obligate the government to any future contract. • Goal: improve supply‑chain transparency and traceability for DLA‑procured pharmaceuticals. • Required data: country of origin for FDF, each API, and each KSM; lot‑level details if variable. • Expected deliverables: labeling construct, FDA approval pathway, sample labels, impact assessment, and recommendations for scaling the pilot. • Submission format: PDF or Word via email to the contracting officer. • No deadline or award date; this is a voluntary information‑gathering effort (RFI).